These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3127336)

  • 1. Role of the antibody Fc in the immune clearance of Trypanosoma cruzi.
    Umekita LF; Takehara HA; Mota I
    Immunol Lett; 1988 Jan; 17(1):85-9. PubMed ID: 3127336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of antibody isotype responsible for immune clearance in mice infected with Trypanosoma cruzi.
    Brodskyn CI; da Silva AM; Takehara HA; Mota I
    Immunol Lett; 1988 Aug; 18(4):255-8. PubMed ID: 3141272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of C3 depletion on the clearance of Trypanosoma cruzi induced by IgG antibodies.
    Mota I; Umekita LF
    Immunol Lett; 1989 Jun; 21(3):223-5. PubMed ID: 2504665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological activity of chronic phase antibodies eluted from sensitized Trypanosoma cruzi trypomastigotes.
    Umekita LF; Ramos DP; Barbaro KC; Mota I
    Immunol Lett; 1999 Nov; 70(2):73-6. PubMed ID: 10569694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IgG subclasses responsible for immune clearance in mice infected with Trypanosoma cruzi.
    Brodskyn CI; Silva AM; Takehara HA; Mota I
    Immunol Cell Biol; 1989 Dec; 67 ( Pt 6)():343-8. PubMed ID: 2516504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IgG-mediated viral clearance in experimental infection with herpes simplex virus type 1: role for neutralization and Fc-dependent functions but not C' cytolysis and C5 chemotaxis.
    McKendall RR
    J Infect Dis; 1985 Mar; 151(3):464-70. PubMed ID: 2982965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Agglutination of Trypanosoma cruzi in infected cells treated with serum from chronically infected mice.
    Wendelken JL; Rowland EC
    J Parasitol; 2009 Apr; 95(2):337-44. PubMed ID: 18922039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Fc fragments in antibody-mediated recovery from ocular and subcutaneous herpes simplex virus infections.
    Oakes JE; Lausch RN
    Infect Immun; 1981 Jul; 33(1):109-14. PubMed ID: 6266961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of reinoculation with trypomastigotes on the level of protective antibodies in mice chronically infected with T. cruzi.
    Pereira ME; Krettli AU
    Braz J Med Biol Res; 1990; 23(3-4):283-92. PubMed ID: 2128821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In-vitro lysis of sensitized Trypanosoma cruzi by platelets: role of C3b receptors.
    Umekita LF; Mota I
    Parasite Immunol; 1989 Sep; 11(5):561-6. PubMed ID: 2531362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transformation of Trypanosoma cruzi trypomastigote bloodstream forms by immune IgM and its Fab mu fragment into activators of the alternative complement pathway.
    Kipnis TL; Sucupira M; da Silva WD
    Braz J Med Biol Res; 1987; 20(1):105-14. PubMed ID: 3318974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of membrane-bound IgM in Trypanosoma cruzi evasion from immune clearance.
    Garcia IE; Lima MR; Marinho CR; Kipnis TL; Furtado GC; Alvarez JM
    J Parasitol; 1997 Apr; 83(2):230-3. PubMed ID: 9105302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of cross-reactivity of lytic antibodies with bloodstream forms of Trypanosoma cruzi zymodemes generated in a mouse experimental model.
    Wallace A; Sanchez G; Venegas J; Solari A
    Exp Parasitol; 1995 Mar; 80(2):176-85. PubMed ID: 7895829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Membrane-bound antibodies to bloodstream Trypanosoma cruzi in mice: strain differences in susceptibility to complement-mediated lysis.
    Krettli AU; Weisz-Carrington P; Nussenzweig RS
    Clin Exp Immunol; 1979 Sep; 37(3):416-23. PubMed ID: 116784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The possible mechanism of action of IgG antibodies and platelets protecting against Trypanosoma cruzi infection.
    Takehara HA; Mota I
    Braz J Med Biol Res; 1991; 24(8):759-65. PubMed ID: 1797263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement-mediated lysis of Trypanosoma cruzi trypomastigotes by human anti-alpha-galactosyl antibodies.
    Almeida IC; Milani SR; Gorin PA; Travassos LR
    J Immunol; 1991 Apr; 146(7):2394-400. PubMed ID: 1706399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody to Trypanosoma cruzi neuraminidase enhances infection in vitro and identifies a subpopulation of trypomastigotes.
    Cavallesco R; Pereira ME
    J Immunol; 1988 Jan; 140(2):617-25. PubMed ID: 3121750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fab' fragments of a mAb to a member of family 2 of trans-sialidases of Trypanosoma cruzi block trypanosome invasion of host cells and neutralize infection by passive immunization.
    Villalta F; Smith CM; Burns JM; Chaudhuri G; Lima MF
    Ann N Y Acad Sci; 1996 Oct; 797():242-5. PubMed ID: 8993367
    [No Abstract]   [Full Text] [Related]  

  • 19. Transformation of trypomastigote forms of Trypanosoma cruzi into activators of alternative complement pathway by immune IgG fragments.
    Kipnis TL; Krettli AU; Dias da Silva W
    Scand J Immunol; 1985 Aug; 22(2):217-26. PubMed ID: 3898353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-lytic antibodies in H-2-controlled resistance to acute infection with Trypanosoma cruzi.
    Juri MA; Ferreira A; Ramos A; Hoecker G
    Braz J Med Biol Res; 1990; 23(8):685-95. PubMed ID: 2129269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.